Superworth

AdvanSix ASIX

Chemicals, Basic Materials
$15.53
+1.11%
Market cap
$419.3M
PE
n/m
a loss over the last year
Forward PE
n/m
not a meaningful number
Price to sales
0.3×
EV/EBIT
n/m
a loss over the last year
Revenue, 12 months
$1.6B
+3% on a year ago
Net margin
−1.1%
Free cash flow yield
−6.1%

AdvanSix trades at 0.3× sales. Its trailing earnings are negative, so it has no PE. Revenue was $1.6B over the last twelve months, up 3% on a year earlier with a −1% net margin.

Charts

Financials

Income statement for ASIX, by quarter
Income statementQ3 FY23Q4 FY23Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
$322.9M−33%$382.2M−5%$336.8M−16%$453.5M+6%$398.2M+23%$329.1M−14%$377.8M+12%$410M−10%$374.5M−6%$359.9M+9%$404.2M+7%$421.3M+3%
Cost of revenue$314.8M−29%$363.7M+9%$333.9M+1%$372.1M+3%$340.9M+8%$317.8M−13%$324.3M−3%$351.3M−6%$349.1M+2%$332.6M+5%$400.4M+24%$390.2M+11%
Gross profit$8.1M−77%$18.5M−73%$3M−96%$81.4M+20%$57.3M+606%$11.3M−39%$53.5M+1703%$58.7M−28%$25.4M−56%$27.4M+142%$3.8M−93%$31.1M−47%
SG&A$21.6M−6%$24.8M+10%$23.6M−6%$24.4M+2%$24.3M+12%$21.7M−13%$23.4M−1%$25.4M+4%$27.4M+13%$28.5M+31%$22.5M−4%$22.1M−13%
−$13.5M−$6.3M−$20.6M$56.9M+30%$33M−$10.4M+66%$30.1M$33.3M−42%−$2M−$1.1M−89%−$18.7M$9M−73%
Interest expense$2.1M+203%$2.2M+187%$2.7M+113%$3.5M+80%$2.9M+41%$2.2M−1%$1.5M−43%$2.3M−36%$2.3M−21%$2.4M+9%$2.4M+58%$2.6M+16%
Pre-tax income−$10.1M−$8.2M−$23.4M$52.1M+20%$29.7M−$12.8M+56%$28.9M$31.6M−39%−$3.5M−$2.6M−80%−$20.7M$6.7M−79%
−$2.1M−$3.2M−$6M$13.1M+25%$7.5M−$13.2M+318%$5.6M$279K−98%−$909K$190K−$5.1M$3.4M+1121%
Net income−$8M−$5.1M−$17.4M$38.9M+19%$22.3M$352K$23.3M$31.4M−19%−$2.6M−$2.8M−$15.5M$3.2M−90%
−$0.29−$0.19−$0.65$1.43+23%$0.82$0.01$0.86$1.15−20%−$0.10−$0.10−$0.58$0.12−90%
27.2M−6%26.9M−6%26.9M−6%27.2M−3%27.2M+0%27.4M+2%27.3M+2%27.2M+0%26.9M−1%26.9M−2%27M−1%27.6M+1%

Gross profit: 44 periods, Q3 FY15 to Q2 FY26: not printed by the filing, worked out from its own lines.

Operating income: 38 periods, Q1 FY17 to Q2 FY26: not printed by the filing, worked out from its own lines.

EPS, diluted: 7 periods, Q4 FY15 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: 7 periods, Q4 FY15 to Q4 FY24: share-days: the 12-month average less the 9-month, weighted by days. 4 periods, Q4 FY16 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Chemicals nearest AdvanSix's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
ASIXAdvanSix$419.3Mn/m9.8×0.3×+3%−1.1%
FTKFlotek Industries$850.1M23.7×27.5×2.9×+37%13.0%
NAGENiagen Bioscience$189.9M13.3×26.5×1.5×+11%12.4%
CRONCronos$1.2B16.6×24.9×6.9×+37%39.1%
ROGRogers$2.3B50.7×34.4×2.7×+7%5.3%
FTLFFitlife Brands$75.4M13.0×15.2×0.7×+61%6.2%
IOSPInnospec$2.5B20.3×22.3×1.3×+3%6.6%
NGVTIngevity$2.5B50.1×20.1×2.2×−4%4.7%
FULFuller H B$2.8B14.4×22.8×0.8×+1%5.6%
WDFCWD 40$3.1B37.5×39.2×4.4×+11%12.0%
CBTCabot$3.9B21.4×14.4×1.1×−5%5.2%
Peer median$2.4B20.9×23.8×1.8×+9%6.4%

More on AdvanSix

Each number over time

Where it ranks

Its groups

About

Industry
Chemicals
Sector
Basic Materials

Valuation data, not investment advice. Prices as of .